2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma
    Journal Article

    Gerecitano, J.; Portlock, C.; Moskowitz, C.; Hamlin, P.; Straus, D.; Zelenetz, A. D.; Zhang, Z.; Dumitrescu, O.; Sarasohn, D.; Lin, D.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • T-Cell project: An international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma
    Journal Article

    Federico, M.; Bellei, M.; Pesce, E.; Zucca, E.; Pileri, S.; Montoto, S.; Weisenburger, D. D.; Ruediger, T.; Ko, Y. H.; Liang, R.; more...
    Revista Brasileira de Hematologia e Hemoterapia (2009)

    Fulltext@MSK | Save
  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: A report of 57 cases from the Research on Adverse Drug Events and Reports project
    Journal Article

    Carson, K. R.; Evens, A. M.; Richey, E. A.; Habermann, T. M.; Focosi, D.; Seymour, J. F.; Laubach, J.; Bawn, S. D.; Gordon, L. I.; Winter, J. N.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Memorial Sloan-Kettering Cancer Center program of cancer and aging. Experience of the 65+ Clinical Geriatric Program in the evaluation of older cancer patients
    Meeting Abstract

    Lichtman, S. M.; Boparai, M.; Labzda, K.; Martin, A. H.; Giustino, J.; Aquino, J. G.; Tew, W. P.; Hamlin, P.; McEvoy, L.; Bailey, G. F.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prevalence of late morbidity in survivors of Hodgkin's lymphoma (HL) treated during adulthood
    Meeting Abstract

    Matasar, M. J.; Butos, J. N.; McCallen, L. N.; Riedel, E. R.; Ford, J. S.; Weinstock, D. M.; Oeffinger, K. C.; Straus, D. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I study evaluating two dosing schedules of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) in patients with relapsed/refractory indolent and mantle cell lymphomas
    Meeting Abstract

    Gerecitano, J. F.; Portlock, C.; Hamlin, P.; Moskowitz, C.; Noy, A.; Straus, D. J.; Zelenetz, A. D.; Schulman, P.; Dumitrescu, O.; O'Connor, O. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of the novel proteasome inhibitor NPI-0052 in patients with lymphoma and solid tumors
    Meeting Abstract

    Aghajanian, C. A.; Hamlin, P.; Gordon, M. S.; Hong, D. S.; Naing, A.; Younes, A.; Hannah, A.; Palladino, M. A.; Spear, M. A.; Kurzrock, R.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Psychosocial functioning in survivors of Hodgkin lymphoma (HL) treated during adulthood
    Meeting Abstract

    Ford, J. S.; Schwartz, J.; McCallen, L. N.; Matasar, M. J.; Butos, J. N.; Riedel, E. R.; Weinstock, D. M.; Oeffinger, K. C.; Straus, D. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Cardiac toxicity
    Book Section

    Yahalom, J.; Portlock, C. S.
    In DeVita, V. T.; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8th ed (2008)

    Fulltext@MSK | Save
  • Lymphomas of the gastrointestinal tract
    Book Section

    Zelenetz, A. D.
    In Kelsen, D. P.; Daly, J. M.; Kern, S. E.; Levin, B.; Tepper, J. E.; Van Cutsem, E. (Eds.) Principles and Practice of Gastrointestinal Oncology. 2nd ed (2008)

    Fulltext@MSK | Save